Nav: Home

The glue that keeps cells together

June 14, 2017

Controlled adhesion and division are crucial for our body's cells. This is the case, for instance, when the organs develop in an embryo or when broken skin is repaired during the healing process.

The importance of close cell-cell adhesion becomes evident especially when it is dysfunctional, for example when cells become loose in a tumour and break free. The tumour cell complex tends to dissolve in this case and create metastases.

Cadherins as key actors

The cadherin proteins assume a central role in the above mentioned examples. Located in the cell membranes, they are capable of creating strong bonds both among themselves and with the cadherins of other cells. A bond between two cadherin molecules of two cells triggers the formation of extensive contact zones.

The process of establishing and detaching contacts seems to be much more dependent on purely physical effects than thought previously. This is shown by computer simulations and experiments published in "Nature Physics" by Dr Susanne Fenz from the University of Würzburg's Biocentre with colleagues from Jülich, Stuttgart, Erlangen and Marseilles.

Connecting model membranes

The biophysicist brought together model membranes containing cadherin and then selectively changed different physical parameters that influence the membrane's fluctuation behaviour such as the concentration of sugar and salt.

"We observed that already very small changes had a huge impact on the formation and growth of cell-cell contacts," says Dr Fenz, who leads a junior research group at the Department for Cell and Developmental Biology (Zoology I). "So it is possible to regulate a biological process by changing only physical parameters such as the temperature or local lipid composition of the membrane."

But according to Fenz, it is still doubtful to what extent the results for the model membranes can be transferred to living systems. "We will have to confirm the relevance of our observations in living systems," says Susanne Fenz.

Focus on pathogens that cause sleeping sickness

The Würzburg researcher has a general interest in the biophysics of membranes. For example, she also studies the pathogens that cause the sleeping sickness. The protozoa of the species Trypanosoma are one of Professor Markus Engstler's focal areas of research; he is the head of the Department for Zoology I at the Julius-Maximilians-Universität (JMU) in Würzburg, Germany.

What's special about the cell membrane of Trypanosoma is that it is densely populated with a protein shell that is varied continuously in a population. This high variability of the protein shell allows the pathogens to hide efficiently from the immune systems of animals and humans.
-end-


University of Würzburg

Related Sleeping Sickness Articles:

Research team finds possible new approach for sleeping sickness drugs
Using ultra-bright X-ray flashes, a team of researchers has tracked down a potential target for new drugs against sleeping sickness: The scientists have decoded the detailed spatial structure of a vital enzyme of the pathogen, the parasite Trypanosoma brucei.
Insight into the neglected tropical disease sleeping sickness
Researchers have shed light on how the parasite which causes sleeping sickness multiples inside its host.
Severe morning sickness associated with higher risk of autism
Children whose mothers had hyperemesis gravidarum -- a severe form of a morning sickness -- during pregnancy were 53% more likely to be diagnosed with autism spectrum disorder, according to Kaiser Permanente research published in the American Journal of Perinatology.
Scientists identify a key gene in the transmission of deadly African sleeping sickness
An international team of life scientists has identified a key gene in the transmission of African sleeping sickness -- a severe disease transmitted by the bite of an infected, blood-sucking tsetse fly, which is common in Sub-Saharan Africa.
Marijuana for morning sickness? It's not great for baby's brain
With a growing number of states legalizing recreational or medical marijuana, more women are using the drug during pregnancy, in part due to its reported ability to relieve morning sickness.
New therapeutic approach to combat African sleeping sickness
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness.
Sleeping sickness parasite uses multiple metabolic pathways
Parasitic protozoa called trypanosomes synthesize sugars using an unexpected metabolic pathway called gluconeogenesis, according to a study published December 27 in the open-access journal PLOS Pathogens by David Horn of the University of Dundee in the UK, and colleagues.
Decoding sleeping sickness signals could aid quest for treatments
Scientists have discovered how the parasite that causes sleeping sickness initiates a physical change in order to spread the disease.
Clemson researchers reveal secrets of parasite that causes African sleeping sickness
A team of Clemson University researchers wants to protect humans and other mammals from the debilitating and even deadly effects of African sleeping sickness.
Motion sickness vs. cybersickness: Two different problems or the same condition?
Contrary to previous research, severe motion sickness and cybersickness -- a type of motion sickness that stems from exposure to virtual reality -- may be considered the same clinical condition, according to researchers.
More Sleeping Sickness News and Sleeping Sickness Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.